Subclavian Artery Thrombosis Treatment & Management

  • Author: Mary C Mancini, MD, PhD; Chief Editor: John Geibel, MD, DSc, MA   more...
 
Updated: Nov 15, 2011
 

Medical Therapy

Early diagnosis and therapy of subclavian artery thrombosis are indicated to prevent disabling upper extremity ischemia and gangrene. As a temporizing measure, the use of catheter-directed thrombolytic therapy may be indicated for superimposed clot formation in an area of stenosis until definitive treatment of the obstruction can be undertaken.[6]

Prolonged anticoagulation therapy for an obvious mechanical problem is not indicated. Anticoagulation may be considered as supplemental therapy after surgical intervention.

Next

Surgical Therapy

Surgery to correct subclavian artery thrombosis is the treatment of choice. Interventions include catheter-based procedures and formal operative procedures.

Angioplasty and stenting of stenotic and even occluded arteries have been undertaken successfully with adequate patency rates and minimal morbidity.[7] These interventions are particularly appropriate for atherosclerotic arteries. A study to determine if stenting alone is superior proved inconclusive.[8]

Subclavian artery occlusion secondary to thoracic outlet syndrome or muscular compression is treated by excision of the anatomical structure compressing the artery, whether muscle or bone.[9] The artery may or may not require additional reconstruction, depending on the presence or absence of intimal damage.

The occluded artery may require a bypass procedure, depending on the location of the occlusion or the presence of a subclavian steal syndrome. The bypass options include subclavian-carotid, subclavian-subclavian, and axillary-axillary bypasses. Another possible bypass option is transposition of the subclavian artery to the ipsilateral carotid artery.

In any operative procedure for the problem, care must be taken to protect the thoracic duct from damage.

Previous
Next

Preoperative Details

After the appropriate diagnostic studies have been performed to define the problem, operative preparation should be made. Administer preoperative prophylactic antibiotic therapy in the form of a first-generation cephalosporin. Perform appropriate preoperative medical screening to assess for evidence of other atherosclerotic disease such as coronary, carotid, or peripheral vascular occlusions.[6]

Previous
Next

Intraoperative Details

For patients in whom the occlusion is secondary to atherosclerotic disease, perform a bypass of the area. For subclavian steal syndrome, a carotid-subclavian bypass using a ribbed synthetic tube graft is the procedure of choice (see image below).

Carotid-subclavian bypass for subclavian steal synCarotid-subclavian bypass for subclavian steal syndrome.

Depending upon the location of the occlusion, subclavian-subclavian or axillary-axillary bypass can be undertaken using a ribbed synthetic conduit (see image below).

Subclavian-subclavian or axillary-axillary bypass Subclavian-subclavian or axillary-axillary bypass for subclavian artery occlusion.

Because of the position of the graft and the necessity to, in some cases, cross bony structures, autologous vein conduits have limited patency.

For patients in whom thoracic outlet compression is the cause of the thrombosis, cervical rib resection via a supraclavicular incision appears to be adequate treatment. Resection of the midportion of the clavicle is sometimes needed for exposure. Undertake arterial resection because the intima of the vessel is damaged. Graft interposition may or may not be required. Redundancy of the normal adjacent artery may allow for end-to-end reconstruction. If a graft is required for arterial reconstruction, a large autogenous saphenous vein or expanded polytetrafluoroethylene or Dacron fabric grafts may be used. First rib resection may be indicated in these instances as well, depending on the size of the thoracic outlet.[10]

In all procedures, care must be taken to identify and preserve the thoracic duct.

Previous
Next

Postoperative Details

Check distal upper extremity pulses immediately after the operative procedure while the field is still sterile. Maintain careful observation for the development of muscular compartment syndromes, and perform compartment measurements if indicated. Concomitant fasciotomies may be indicated, depending on the length of ischemia suffered by the extremity prior to revascularization.

Evaluate postoperative effusions for the presence of chyle, which would be indicative of thoracic duct injury. Undertake prompt therapeutic measures if this complication occurs.

Previous
Next

Follow-up

Perform postprocedural angiography at prescribed times after the operative intervention in order to assess patency of the graft or stent. One suggested timing sequence for the studies is at 1 month and 6 months, provided the patient remains asymptomatic. Noninvasive Doppler imaging can be used to assess distal flow to the extremity in the interim.

Previous
Next

Complications

Potential complications of subclavian artery thrombosis secondary to atherosclerotic disease include distal embolization to the digits and neurological symptoms, including stroke secondary to a steal syndrome. Complications from operative interventions to address the arterial occlusion can include graft occlusion (acute and chronic), stent migration, stent occlusion, bleeding, and infection.

If the subclavian artery thrombosis is secondary to thoracic outlet problems, subclavian vein thrombosis can occur as well.[11] Accompanying neurological symptoms resulting from brachial plexus compression can also be associated with the syndrome. Repair of the arterial thrombosis can again be complicated by graft thrombosis. Although rare, the possibility of postoperative bleeding should be reviewed with the patient before the operative intervention. Promptly address bleeding complications by reoperation in order to correct the problem.

Complications of the operative procedure can include injury to the thoracic duct. Pleural effusions should be promptly evaluated and appropriately treated.

Previous
Next

Outcome and Prognosis

The results from stenting procedures on the subclavian artery document an 87% patency rate after 3 years. Operative outcomes demonstrate about a 90% patency rate after 5 years.

The prognosis for the patient with atherosclerotic disease is directly dependent upon the severity of the disease and the willingness of the patient to modify lifestyle, including cessation of tobacco use and regulation of diet. If these modifications are made, the progression of the atherosclerotic process slows and the chance for recurrence of thrombosis falls.

For the patient whose occlusion is secondary to thoracic outlet problems, the prognosis after therapy is excellent.

Previous
Next

Future and Controversies

The future therapy of subclavian artery thrombosis will most likely involve the use of endovascular stents.[12, 13] As technology improves and a better understanding of restenosis issues is achieved, stenting of the lesions will be more commonplace.[14, 15]

Careful assessment of patients with thoracic outlet syndrome will be required because of the complexity of this problem, the multiple structures involved, and the high-profile medicolegal issues that arise with treatment of these patients. Operative treatment of the arterial complications of the thoracic outlet syndrome should be performed. However, careful evaluation of the potentially associated venous and neurological pathologies should be undertaken prior to any operative therapy.

Previous
 
Contributor Information and Disclosures
Author

Mary C Mancini, MD, PhD  Professor and Chief of Cardiothoracic Surgery, Department of Surgery, Louisiana State University School of Medicine in Shreveport

Mary C Mancini, MD, PhD is a member of the following medical societies: American Association for Thoracic Surgery, American College of Surgeons, American Surgical Association, Phi Beta Kappa, Society of Thoracic Surgeons, and Southern Surgical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Jeffrey Lawrence Kaufman, MD  Associate Professor, Department of Surgery, Division of Vascular Surgery, Tufts University School of Medicine

Jeffrey Lawrence Kaufman, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, American Society for Artificial Internal Organs, Association for Academic Surgery, Association for Surgical Education, Massachusetts Medical Society, Phi Beta Kappa, and Society for Vascular Surgery

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Daniel S Schwartz, MD, FACS  Assistant Clinical Professor of Cardiothoracic Surgery, Mount Sinai School of Medicine; Chief of Thoracic Surgery, Huntington Hospital

Daniel S Schwartz, MD, FACS is a member of the following medical societies: American College of Chest Physicians, American College of Surgeons, Society of Thoracic Surgeons, and Western Thoracic Surgical Association

Disclosure: Nothing to disclose.

Paolo Zamboni, MD  Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy

Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences

Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, DSc, MA  Vice Chair and Professor, Department of Surgery, Section of Gastrointestinal Medicine, and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director, Surgical Research, Department of Surgery, Yale-New Haven Hospital

John Geibel, MD, DSc, MA is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, and Society for Surgery of the Alimentary Tract

Disclosure: AMGEN Royalty Consulting; ARdelyx Ownership interest Board membership

References
  1. Nuber GW, McCarthy WJ, Yao JS, Schafer MF, Suker JR. Arterial abnormalities of the shoulder in athletes. Am J Sports Med. Sep-Oct 1990;18(5):514-9. [Medline].

  2. Nehler MR, Taylor LM Jr, Moneta GL, Porter JM. Upper extremity ischemia from subclavian artery aneurysm caused by bony abnormalities of the thoracic outlet. Arch Surg. May 1997;132(5):527-32. [Medline].

  3. Mandalam KR, Rao VR, Gupta AK, Joseph S, Unni NM, Rao AS. Occlusion of an aberrant right subclavian artery arising from a Kommerel diverticulum. J Vasc Interv Radiol. Jul-Aug 1993;4(4):577-9. [Medline].

  4. Zimmerman NB. Occlusive vascular disorders of the upper extremity. Hand Clin. Feb 1993;9(1):139-50. [Medline].

  5. Laitt RD, Thompson JF, Goddard P, Wakeley CJ, Murphy P, Lamont P. Subclavian artery aneurysm: the role of magnetic resonance imaging. Cardiovasc Surg. Oct 1994;2(5):612-4. [Medline].

  6. Rogers JH, Calhoun RF 2nd. Diagnosis and management of subclavian artery stenosis prior to coronary artery bypass grafting in the current era. J Card Surg. Jan-Feb 2007;22(1):20-5. [Medline].

  7. Dave B, Bhatt N, Gupta M, Khalasi Y, Balasubramanya KS. Subclavian artery thrombosis--management with thrombolysis and angioplasty. J Indian Med Assoc. Sep 2004;102(9):519-20, 527. [Medline].

  8. Burihan E, Soma F, Iared W. Angioplasty versus stenting for subclavian artery stenosis. Cochrane Database Syst Rev. Oct 5 2011;CD008461. [Medline].

  9. Fugate MW, Rotellini-Coltvet L, Freischlag JA. Current management of thoracic outlet syndrome. Curr Treat Options Cardiovasc Med. Apr 2009;11(2):176-83. [Medline].

  10. Thompson JF, Webster JH. First rib resection for vascular complications of thoracic outlet syndrome. Br J Surg. May 1990;77(5):555-7. [Medline].

  11. Hood DB, Kuehne J, Yellin AE, Weaver FA. Vascular complications of thoracic outlet syndrome. Am Surg. Oct 1997;63(10):913-7. [Medline].

  12. Cohen JE, Rajz G, Gomori JM, Verstandig A, Berlatzky Y, Anner H, et al. Urgent endovascular stent-graft placement for traumatic penetrating subclavian artery injuries. J Neurol Sci. Sep 15 2008;272(1-2):151-7. [Medline].

  13. Shalhub S, Starnes BW, Hatsukami TS, Karmy-Jones R, Tran NT. Repair of blunt thoracic outlet arterial injuries: an evolution from open to endovascular approach. J Trauma. Nov 2011;71(5):E114-21. [Medline].

  14. Varcoe R, Smith W. Use of a cutting balloon and a paclitaxel-coated balloon to treat recurrent subclavian in-stent restenosis causing coronary subclavian steal syndrome. Cardiovasc Revasc Med. Jul 26 2011;[Medline].

  15. Miyakoshi A, Hatano T, Tsukahara T, Murakami M, Arai D, Yamaguchi S. Percutaneous transluminal angioplasty for atherosclerotic stenosis of the subclavian or innominate artery: angiographic and clinical outcomes in 36 patients. Neurosurg Rev. Jun 4 2011;[Medline].

  16. Baraki H, Hagl C, Khaladj N, Kallenbach K, Weidemann J, Haverich A. The frozen elephant trunk technique for treatment of thoracic aortic aneurysms. Ann Thorac Surg. Feb 2007;83(2):S819-23; discussion S824-31. [Medline].

  17. Boas N, Desmoucelle F, Bernadet V, Franceschi JC. Rare cause of acute ischemia of the right upper extremity: thrombosis of a retroesophageal subclavian artery. Ann Vasc Surg. May 2002;16(3):387-90. [Medline].

  18. Dagenais F, Dumont E, Voisine P. Intramural hematoma of the arch and ascending aorta owing to acute aortic syndrome of the descending aorta: to stent or not to stent?. J Endovasc Ther. Oct 2008;15(5):544-9. [Medline].

  19. Edwards WH. An unsuspected cause for recurrent angina: subclavian artery stenosis. Am Surg. Dec 1995;61(12):1057-60. [Medline].

  20. Fan Z, Roedersheimer R, Lohr J. Systemic thrombolysis using tissue plasminogen activator for a patient with paradoxic embolism: a case report. Vasc Endovascular Surg. Apr-May 2007;41(2):136-9. [Medline].

  21. Golcman L, Berginer VM, Szendro G, Hoda J, Louson Z. Prominent somnolence and cerebellar syndrome in subclavian artery thrombosis--a case report. Angiology. Dec 1987;38(12):912-5. [Medline].

  22. Hay E, Cohen H, Pasik S. Acute thrombosis of subclavian artery during CPR. Ann Emerg Med. Apr 1987;16(4):447-51. [Medline].

  23. Hendler MF, Meschengieser SS, Blanco AN, Alberto MF, Salviú MJ, Gennari L. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects. Am J Hematol. Aug 2004;76(4):330-7. [Medline].

  24. Henry M, Amor M, Henry I. Percutaneous transluminal angioplasty of the subclavian arteries. J Endovasc Surg. Feb 1999;6(1):33-41. [Medline].

  25. Mendelsohn AM, Buzzard CJ, Lerner NB, Ling FS. Transumbilical balloon angioplasty of subclavian artery thrombosis in a neonate. Catheter Cardiovasc Interv. Jan 2000;49(1):56-60. [Medline].

  26. Rapp JH, Reilly LM, Goldstone J, Krupski WC, Ehrenfeld WK, Stoney RJ. Ischemia of the upper extremity: significance of proximal arterial disease. Am J Surg. Jul 1986;152(1):122-6. [Medline].

  27. Riesenman PJ, Farber MA, Mendes RR, Marston WA, Fulton JJ, Keagy BA. Coverage of the left subclavian artery during thoracic endovascular aortic repair. J Vasc Surg. Jan 2007;45(1):90-4; discussion 94-5. [Medline].

  28. Tyagi S, Rangasetty UC, Kaul UA. Stenting of a large thrombus-containing subclavian artery stenosis using a distal protection device. Indian Heart J. May-Jun 2003;55(3):262-4. [Medline].

  29. Vanherweghem JL, Cabolet P, Dhaene M, Goldman M, Stolear JC, Sabot JP. Complications related to subclavian catheters for hemodialysis. Report and review. Am J Nephrol. 1986;6(5):339-45. [Medline].

  30. Vinsonneau U, Castellant P, Traore A, Cornily JC, Pennec PY, Etienne Y, et al. [Floating thrombus in an aberrant right subclavian artery: a rare cause of peripheral arterial embolic events]. Rev Med Interne. Nov 2008;29(11):908-11. [Medline].

  31. Witz M, Lehman J, Shnaker A, Korzets Z. Acute subclavian and brachial artery thrombosis as a complication of the nephrotic syndrome. Isr Med Assoc J. Jul 2004;6(7):441-2. [Medline].

  32. Witz M, Lehmann J, Korzets Z. Acute brachial artery thrombosis as the initial manifestation of human immunodeficiency virus infection. Am J Hematol. Jun 2000;64(2):137-9. [Medline].

  33. Zeller T, Frank U, Bürgelin K, Sinn L, Horn B, Roskamm H. Acute thrombotic subclavian artery occlusion treated with a new rotational thrombectomy device. J Endovasc Ther. Dec 2002;9(6):917-21. [Medline].

Previous
Next
 
The anatomy of the subclavian artery in the thoracic outlet.
Carotid-subclavian bypass for subclavian steal syndrome.
Subclavian-subclavian or axillary-axillary bypass for subclavian artery occlusion.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.